...
首页> 外文期刊>Nanotechnology >Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells
【24h】

Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells

机译:Fe3O4纳米粒子的生物相容性通过使用正常,胶质细胞和乳腺癌细胞的体外细胞毒性试验评估

获取原文
获取原文并翻译 | 示例
           

摘要

In order to reveal the biocompatibility of Fe3O4 nanoparticles and bipolar surfactant tetramethylammonium 11-aminoundecanoate cytotoxicity tests were performed as a function of concentration from low (0.1 mu g ml(-1)) to higher concentration (100 mu g ml(-1)) using various human glia, human breast cancer and normal cell lines. Cytotoxicity tests for human glia (D54MG, G9T, SF126, U87, U251, U373), human breast cancer (MB157, SKBR3, T47D) and normal (H184B5F5/M10, WI-38, SVGp12) cell lines exhibited almost nontoxicity and reveal biocompatibility of Fe3O4 nanoparticles in the concentration range of 0.1-10 mu g ml(-1), while accountable cytotoxicity can be seen at 100 mu g ml(-1). The results of our studies suggest that Fe3O4 nanoparticles coated with bipolar surfactant tetramethylammonium 11-aminoundecanoate are biocompatible and promising for bio-applications such as drug delivery, magnetic resonance imaging and magnetic hyperthermia.
机译:为了揭示Fe3O4纳米颗粒和双极性表面活性剂四甲基铵11-氨基十一酸酯的生物相容性,进行了细胞毒性试验,测试浓度从低(0.1μg ml(-1))到高浓度(100μg ml(-1))为函数。使用各种人类胶质细胞,人类乳腺癌和正常细胞系。对人神经胶质细胞(D54MG,G9T,SF126,U87,U251,U373),人乳腺癌(MB157,SKBR3,T47D)和正常(H184B5F5 / M10,WI-38,SVGp12)细胞毒性测试显示几乎无毒并显示出生物相容性Fe3O4纳米颗粒的浓度范围为0.1-10μgml(-1),而在100μgml(-1)处可见明显的细胞毒性。我们的研究结果表明,涂​​覆有双极性表面活性剂11-氨基十一酸四甲基铵的Fe3O4纳米颗粒具有生物相容性,并有望用于生物应用,如药物递送,磁共振成像和磁热疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号